Cody A Rutledge1, Brett A Kaufman2, Cameron Dezfulian3, Jonathan Elmer4. 1. Division of Cardiology, Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: rutledca@pitt.edu. 2. Division of Cardiology, Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 3. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. 4. Departments of Emergency Medicine, Critical Care Medicine, and Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
INTRODUCTION: Metformin is a first-line diabetic therapy that improves survival in a wide number of ischemic pathologies. We tested the association of metformin with markers of cardiac and renal injury in diabetic post-arrest patients. METHODS: We performed a retrospective analysis of clinical outcomes in diabetic cardiac arrest patients with and without metformin therapy at a single academic medical center. We used generalized linear models to test the independent association of metformin, insulin, and other hypoglycemic agents with peak 24-hour serum creatinine and peak 24-hour serum troponin. RESULTS: Metformin prescription at the time of SCA was independently associated with lower 24-hour peak serum troponin and lower 24-hour peak serum creatinine when compared to non-metformin patients. CONCLUSION: Metformin pretreatment may offer cardiac and renal protection for diabetic patients during sudden cardiac arrest.
INTRODUCTION: Metformin is a first-line diabetic therapy that improves survival in a wide number of ischemic pathologies. We tested the association of metformin with markers of cardiac and renal injury in diabetic post-arrest patients. METHODS: We performed a retrospective analysis of clinical outcomes in diabetic cardiac arrest patients with and without metformin therapy at a single academic medical center. We used generalized linear models to test the independent association of metformin, insulin, and other hypoglycemic agents with peak 24-hour serum creatinine and peak 24-hour serum troponin. RESULTS: Metformin prescription at the time of SCA was independently associated with lower 24-hour peak serum troponin and lower 24-hour peak serum creatinine when compared to non-metformin patients. CONCLUSION: Metformin pretreatment may offer cardiac and renal protection for diabetic patients during sudden cardiac arrest.
Authors: Manuel Ruiz-Bailén; Eduardo Aguayo de Hoyos; Silvia Ruiz-Navarro; Miguel Angel Díaz-Castellanos; Luis Rucabado-Aguilar; Francisco Javier Gómez-Jiménez; Sergio Martínez-Escobar; Rafael Melgares Moreno; Javier Fierro-Rosón Journal: Resuscitation Date: 2005-08 Impact factor: 5.262
Authors: G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller Journal: J Clin Invest Date: 2001-10 Impact factor: 14.808
Authors: Yoo Seok Park; Yoon Hee Choi; Je Hyeok Oh; In Soo Cho; Kyoung-Chul Cha; Byung-Sun Choi; Je Sung You Journal: Crit Care Date: 2019-07-15 Impact factor: 9.097